East Meets West, Technique Meets Technology: Professor Antonio Arroyo Shares Cutting-edge Advances of Hugo Robotic Surgery System and New Paradigms in Colorectal Surgery
To promote international academic exchange and share the latest advancements in colorectal surgery, Professor Ding Kefeng’s team at the Second Affiliated Hospital of Zhejiang University School of Medicine meticulously organized the 2026 "China-Spain-Canada Colorectal Surgery Clinical Practice Symposium." The conference invited Professor Antonio Arroyo, President of the Spanish Association of Coloproctology (AECP) and Director of Surgery at Hospital General Universitario de Elche, as the keynote speaker to deliver an in-depth presentation on the Hugo robotic surgery system.
Professor Xiaofan Zhu: Advancing Collaboration, Standardization, and Innovation to Shape a New Blueprint for Pediatric Leukemia Care | 2026 CACA Western Integrated Oncology Conference
To further expand access to high-quality cancer care resources, promote equitable distribution, and enhance the academic and clinical capacity of oncology care in western China and at the grassroots level, the 2026 CACA Western Integrated Oncology Conference was successfully held in Chengdu on April 18, 2026. The conference provided a high-level platform for academic exchange and translational collaboration in oncology.
Preview | The 23rd World Congress on Breast Cancer and Breast Healthcare to Be Held in Tianjin
To further promote academic exchange and practical collaboration in the global field of breast health, and to advance the standardized prevention and treatment of breast cancer, the 23rd World Congress on Breast Cancer and Breast Healthcare will be held in Tianjin, China, from May 8–10, 2026.
Leading the Frontier, Shaping the Future | The Inaugural CSH–IACH Joint Symposium on “From Classics to Innovation: Advances in CAR-T Therapy” Successfully Concluded
The diagnosis and treatment of hematologic diseases remain a global challenge. In recent years, with the rapid emergence of innovative therapies such as chimeric antigen receptor T-cell (CAR-T) therapy and the deepening understanding of hematologic disorders, the field has entered a new era.
AACR 2026 | Qilu Pharmaceutical Showcases 12 Innovative Programs on the Global Stage: A Comprehensive Overview of ADCs, TCEs, Small-Molecule Inhibitors, and a Precision Oncology Portfolio
At the recently concluded 2026 Annual Meeting of the American Association for Cancer Research (AACR), Qilu Pharmaceutical presented 12 innovative oncology programs, including one oral presentation and eleven poster presentations. These studies span a wide range of tumor types, including gynecologic cancers, breast cancer, esophageal cancer, lung cancer, head and neck cancers, colorectal cancer, prostate cancer, diffuse large B-cell lymphoma (DLBCL), and acute myeloid leukemia (AML).
CSCO Guidelines Conference 2026 | Professor Jun Zhu: Redefining the Future of Lymphoma Care—Guideline Updates Shaping a “China Solution”
To advance clinical oncology in China, enhance physicians’ diagnostic and research capabilities, and further promote the development and implementation of CSCO guidelines, the Chinese Society of Clinical Oncology (CSCO), together with the Beijing CSCO Clinical Oncology Research Foundation, co-hosted the 2026 CSCO Guidelines Conference in Harbin from April 24 to 25.
EBMT Global Perspective | Professor Donal McLornan: Defining Remission Criteria and Optimizing Novel Combination Strategies for Bone Marrow Transplantation in MDS/MPN Overlap Syndromes
Myelodysplastic/myeloproliferative neoplasm (MDS/MPN) overlap syndromes are rare hematologic malignancies characterized by marked clinical heterogeneity and significant diagnostic and therapeutic challenges. Allogeneic hematopoietic stem cell transplantation remains a key treatment option; however, the lack of standardized criteria for assessing post-transplant remission and relapse represents a major unmet clinical need.